As expected, FIS treatment obviously decreased levels of inflammatory cytokines (TNF-α, IL-6 and IL-1β) and pro-fibrosis factor (TGF-β) in the BLAF of BLM-induced mice, exerted its anti-inflammatory effect. This evidence concerns the gene IL1B and Bloom syndrome.